Improved preventative care for diabetes has cut the rate of serious complications such as heart attack and stroke over the past 20 years in the U.S. while the number Americans diagnosed with the disease continues to rise, a government report found.
Medtronic Inc. isn’t giving up on a new approach to treat hypertension with a device designed to sear the nerves that spur high blood pressure, even though the first rigorous trial of the method failed to help patients, company officials said.
Weight-loss surgery may be a better way to treat diabetes than traditional drug therapy alone, according to a study that found the operation was more likely to keep the chronic condition at bay for at least three years.
A top U.S. regulator is discrediting research published a year ago that found impurities in dozens of generic heart drugs made overseas, saying the investigators contaminated the samples during their testing.
Eating food high in fish oils such as omega-3 doesn’t reduce the risk of heart disease, raising questions about national guidelines promoting the fats as beneficial for cardiovascular health, researchers found.
Bayer AG will have to share more data about the quality of life for patients who take its costly new cancer medicine Stivarga after a request from a German panel that makes coverage decisions for public insurers.